Company / Depreciation & Amortization
INOVIO PHARMACEUTICALS, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.8M
FY2025
5-year range
$1.8M / $3.6M
FY2021-FY2025
Trend
-33.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $626,554 in FY2016 to $4M in FY2020.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -14.1%.
Improved from $3M to $2M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -16.8%
- 5-Year CAGR
- -14.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.1%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 33.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8M | -33.2% |
| FY2024 | $2.6M | -13.8% |
| FY2023 | $3.0M | +0.0% |
| FY2022 | $3.0M | -15.5% |
| FY2021 | $3.6M | -4.0% |
| FY2020 | $3.7M | +102.5% |
| FY2019 | $1.9M | +8.3% |
| FY2018 | $1.7M | +63.0% |
| FY2017 | $1.0M | +67.3% |
| FY2016 | $626.6K | +90.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026